Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Early Intervention, Educational × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 13 Colorectal Neoplasms 13 Lung Neoplasms 10 Lymphoma 5 Papillomavirus Infections 4 Hematologic Neoplasms 4 Anatomic Stage I Breast Cancer AJCC v8 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Malignant Solid Neoplasm 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Skin Carcinoma 2 Ovarian Neoplasms 2 Obesity-Related Malignant Neoplasm 2 Multiple Myeloma 2 Hematopoietic and Lymphoid System Neoplasm 2 Healthy Subject 2 Genital Neoplasms, Female 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Advanced Malignant Solid Neoplasm 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡